Tirzepatide Weight Loss Therapy
The most powerful GLP-1 medication available for weight loss. Tirzepatide's dual-action mechanism produces greater results than semaglutide alone — with clinical trial data showing an average of 22.5% body weight loss. Prescribed and monitored at Rewind Anti-Aging of Miami.
What Is Tirzepatide?
Tirzepatide is a first-in-class medication that activates two incretin hormone receptors simultaneously — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual receptor agonist was developed by Eli Lilly and has become the most effective injectable weight loss medication available based on clinical trial outcomes.
Originally developed for Type 2 diabetes, tirzepatide produced unprecedented weight loss in trials — surpassing every other pharmaceutical weight loss intervention studied to date. It is now FDA-approved for both diabetes (as Mounjaro) and chronic weight management (as Zepbound).
At Rewind Anti-Aging of Miami, tirzepatide is one of several medication options in our medical weight loss program. Our providers evaluate your metabolic profile, health history, and goals to determine the best fit.
The Dual Mechanism Explained
What makes tirzepatide fundamentally different: while semaglutide activates only GLP-1 receptors, tirzepatide activates both GLP-1 and GIP receptors — two distinct hormonal pathways working together.
GLP-1 Receptor Activation
Suppresses appetite by acting on satiety centers in the hypothalamus, slows gastric emptying, improves insulin sensitivity, and reduces reward-driven eating by dampening the neurological response to high-calorie foods.
GIP Receptor Activation
The additional advantage. GIP signaling promotes the breakdown of stored fat, improves lipid handling, and works synergistically with GLP-1 for greater appetite suppression and better insulin dynamics.
GIP Receptor: The Additional Advantage
- Enhanced fat metabolism — promotes breakdown and mobilization of stored fat for energy
- Improved lipid handling — reduces fat accumulation by regulating how your body processes dietary fats
- Synergistic appetite suppression — combined GLP-1 + GIP activation is greater than either hormone alone
- Better insulin dynamics — more effective blood sugar regulation, reducing the metabolic drive to store fat
In simple terms: semaglutide attacks weight loss from one hormonal angle. Tirzepatide attacks it from two.
The SURMOUNT-1 Trial
Published in the New England Journal of Medicine (July 2022), the landmark SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight plus at least one comorbidity, without Type 2 diabetes.
body weight loss (~34 lbs)
body weight loss (~45 lbs)
body weight loss (~52 lbs)
body weight loss
At the highest dose, more than one-third of participants lost 25% or greater — results that approach bariatric surgery outcomes without any procedure. Over 90% achieved at least 5% weight loss. Additional SURMOUNT trials confirmed benefits for Type 2 diabetes (SURMOUNT-2), long-term maintenance (SURMOUNT-3), and cardiovascular risk reduction (SURMOUNT-4).
The impact of Tirzepatide on a real patient's body composition.
Tirzepatide vs. Semaglutide
Both are highly effective GLP-1 medications, but they are not identical. Understanding the differences helps you and your provider make the right choice.
| Factor | Tirzepatide | Semaglutide |
|---|---|---|
| Mechanism | Dual GLP-1 + GIP agonist | GLP-1 agonist only |
| Avg. Weight Loss | 22.5% (SURMOUNT-1) | 14.9% (STEP 1) |
| Weight Loss Brand | Zepbound | Wegovy |
| Diabetes Brand | Mounjaro | Ozempic |
| Dose Range | 2.5mg - 15mg | 0.25mg - 2.4mg |
| Titration Period | 20-24 weeks to max | 16-20 weeks to max |
| Insulin Sensitivity | Greater improvement (dual pathway) | Significant improvement |
When Tirzepatide May Be Better
- You need to lose a significant amount (50+ pounds)
- You have insulin resistance, prediabetes, or Type 2 diabetes
- You tried semaglutide and plateaued or had inadequate results
When Semaglutide May Be Better
- You have moderate weight loss goals (20-40 pounds)
- Cost or insurance coverage is a primary consideration
- You are already responding well to semaglutide
Tirzepatide Dosing Schedule
A structured dose titration protocol designed to maximize weight loss while minimizing GI side effects. Not every patient needs to reach 15mg — many achieve excellent results at 7.5mg or 10mg. Learn more about how long it takes to lose weight on Mounjaro.
Initial tolerance — not yet a therapeutic dose for weight loss
First therapeutic dose — appetite reduction begins noticeably
Significant appetite suppression for most patients
Many patients reach goal weight at this dose
Advanced dose for patients needing additional weight loss
Highest approved dose — 22.5% avg weight loss in trials
Dose increases are made every 4 weeks minimum, though your provider may hold at a dose longer if you are responding well or experiencing side effects. The full titration to 15mg takes a minimum of 20 weeks.
Side Effects and Safety
Tirzepatide has a well-characterized safety profile from multiple large-scale clinical trials involving thousands of patients.
Common Side Effects
Typically occur during dose titration and are temporary.
- Nausea — Most common, reported by ~25-30% of participants; usually mild and improves within 1-2 weeks of each dose increase
- Diarrhea — Reported by ~15-20% of participants, typically transient
- Constipation — Manageable with adequate hydration and fiber intake
- Decreased appetite — A therapeutic effect rather than a true side effect, though it can feel unfamiliar initially
- Abdominal discomfort — Mild bloating, usually during the first week of a new dose
Serious but Rare Risks
We review your complete medical history before prescribing.
- Pancreatitis: Seek immediate attention for severe, persistent abdominal pain radiating to the back
- Gallbladder issues: Rapid weight loss increases gallstone risk; watch for right upper abdominal pain after fatty foods
- Thyroid C-cell tumors (boxed warning): Contraindicated in patients with personal or family history of MTC or MEN 2 syndrome
Who Is a Candidate for Tirzepatide?
- BMI of 30 or greater (obesity)
- BMI of 27 or greater with a weight-related condition (diabetes, hypertension, dyslipidemia, sleep apnea)
- Previous unsuccessful weight loss attempts through diet and exercise
- Insulin resistance or prediabetes — tirzepatide's dual mechanism is particularly effective here
- Plateau on semaglutide — patients who stopped losing weight may benefit from switching
Who Should NOT Take Tirzepatide
- BMI under 27 without weight-related comorbidities
- Pregnant, planning to become pregnant, or breastfeeding
- History of medullary thyroid cancer, MEN 2 syndrome, or pancreatitis
- Severe gastroparesis or other serious gastrointestinal conditions
- Under 18 years of age
What to Expect During Treatment
Initial Consultation
Discuss your weight loss goals, health history, previous diets and medications. Available in-person at our Miami clinic or via telehealth.
Comprehensive Lab Work
Full metabolic and hormonal blood panel to assess baseline health, identify contraindications, and establish biomarkers for tracking.
Treatment Plan & Prescription
Your provider reviews labs, confirms candidacy, and prescribes your starting dose of tirzepatide 2.5mg weekly.
Injection Training
Our team teaches you proper subcutaneous injection technique, storage, and what to expect during the first week.
Monthly Follow-ups
Track weight, review side effects, adjust dose per titration schedule, and provide nutritional and lifestyle guidance.
Maintenance Phase
As you approach your goal weight, we transition to a structured maintenance plan with dose reduction or supervised taper.
Tirzepatide vs. Mounjaro vs. Zepbound
For a complete breakdown, read our blog post on tirzepatide vs Mounjaro.
Tirzepatide
The active pharmaceutical ingredient (the molecule). The generic name, similar to how "acetaminophen" is the generic name for Tylenol.
Mounjaro
Brand name FDA-approved for Type 2 diabetes. Approved May 2022 by Eli Lilly.
Zepbound
Brand name FDA-approved for chronic weight management in adults with obesity or overweight. Approved November 2023.
All three refer to the exact same molecule. The distinction is purely regulatory. Tirzepatide is also available through licensed 503B compounding pharmacies that produce the medication under FDA oversight.
Related Treatments
Semaglutide Therapy
GLP-1 receptor agonist with proven 14.9% average weight loss in the landmark STEP clinical trials.
Learn more →Tesofensine Therapy
Oral triple reuptake inhibitor that reduces appetite and boosts metabolism through a different pathway.
Learn more →Medical Weight Loss
Comprehensive physician-supervised weight loss programs combining medication, labs, and lifestyle coaching.
Learn more →Explore Tirzepatide in Depth
Tirzepatide Benefits: What the Research Shows
Clinical evidence for tirzepatide's effects on weight and metabolic health.
Tirzepatide vs Mounjaro: What's the Difference?
Understanding the brand name vs the active ingredient.
How Long Does It Take to Lose Weight on Mounjaro?
Realistic timelines and what to expect from tirzepatide therapy.
Tirzepatide and Alcohol: What You Should Know
Important guidance on alcohol during tirzepatide treatment.
Tirzepatide vs Semaglutide
Comparing the two most popular GLP-1 weight loss medications.
Frequently Asked Questions About Tirzepatide
How much weight can I lose with tirzepatide?
The SURMOUNT-1 clinical trial showed participants lost an average of 22.5% of their body weight at the highest dose (15mg) over 72 weeks — approximately 52 pounds. Individual results vary based on starting weight, dosage, adherence to lifestyle modifications, and metabolic factors. Many patients at our clinic lose 40-60+ pounds during treatment.
What is the difference between tirzepatide, Mounjaro, and Zepbound?
They are all the same molecule — tirzepatide — manufactured by Eli Lilly. Mounjaro is the brand name approved for Type 2 diabetes, and Zepbound is the brand name approved specifically for chronic weight management. The active ingredient, mechanism of action, and dosing schedule are identical. Your provider may also prescribe compounded tirzepatide from a licensed 503B compounding pharmacy.
Is tirzepatide better than semaglutide for weight loss?
Head-to-head data and cross-trial comparisons consistently show tirzepatide produces greater average weight loss than semaglutide — 22.5% vs. 14.9% of body weight in their respective landmark trials. However, 'better' depends on your individual response, tolerance, health history, and goals. Some patients respond exceptionally well to semaglutide. Our medical team recommends the best option based on your complete clinical picture.
How long does it take for tirzepatide to start working?
Most patients notice a significant reduction in appetite and food noise within the first 1-2 weeks of treatment. Measurable weight loss typically begins within 2-4 weeks. However, because tirzepatide follows a gradual dose titration schedule starting at 2.5mg, the most significant weight loss accelerates as you reach higher therapeutic doses around weeks 12-20.
What are the most common side effects of tirzepatide?
The most common side effects are gastrointestinal — nausea, diarrhea, constipation, and decreased appetite. These typically occur during dose increases and improve within 1-2 weeks as your body adjusts. The gradual titration schedule is specifically designed to minimize these effects. Serious but rare side effects include pancreatitis and gallbladder issues. Your provider monitors you closely throughout treatment.
How is tirzepatide administered?
Tirzepatide is a once-weekly subcutaneous injection administered in the abdomen, thigh, or upper arm. Most patients self-inject at home after receiving training from our clinical team during their first visit. The injection uses a thin needle and takes less than 30 seconds. You choose the same day each week for consistency.
Can I take tirzepatide if I don't have diabetes?
Yes. While Mounjaro (tirzepatide) was originally approved for Type 2 diabetes, Zepbound (tirzepatide) is FDA-approved specifically for chronic weight management in adults with obesity (BMI 30 or above) or overweight (BMI 27 or above) with at least one weight-related condition such as hypertension, high cholesterol, or sleep apnea. You do not need to have diabetes to qualify.
What happens when I stop taking tirzepatide?
Weight regain is possible if medication is discontinued abruptly without sustainable lifestyle changes in place. Research shows that patients who stop GLP-1 medications without a maintenance plan regain approximately two-thirds of their lost weight within a year. That is why our program includes a structured maintenance phase with gradual dose tapering, nutritional guidance, exercise planning, and ongoing metabolic monitoring to help you sustain your results.
Find Out If Tirzepatide Is Right for You
Schedule a consultation with our medical team to review your labs, discuss your goals, and determine whether tirzepatide is the best weight loss medication for your body.
⚕ Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. All treatments at Rewind Anti-Aging of Miami are performed under the supervision of licensed medical professionals. Individual results may vary. Consult your physician before beginning any new treatment protocol.
Meet our clinical team →Areas We Serve in Miami & South Florida
Our Wynwood clinic at 24 NW 29th Street serves patients across the Miami metro in person and the entire state of Florida via telehealth.